[
    [
        {
            "time": "2020-04-30",
            "original_text": "资金提前动手了 硬核科技股“王者归来” 节后行情值得期待(附一季报业绩大增优质个股名单)",
            "features": {
                "keywords": [
                    "硬核科技股",
                    "王者归来",
                    "节后行情",
                    "一季报业绩大增"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "资金提前动手了 硬核科技股“王者归来” 节后行情值得期待(附一季报业绩大增优质个股名单)",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-04-30",
            "original_text": "【招商策略】2020年4月陆股通持股分析——北上资金放量回流，加仓食品饮料、医药和电子",
            "features": {
                "keywords": [
                    "北上资金",
                    "放量回流",
                    "食品饮料",
                    "医药",
                    "电子"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "食品饮料",
                    "医药",
                    "电子"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【招商策略】2020年4月陆股通持股分析——北上资金放量回流，加仓食品饮料、医药和电子",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-04-30",
            "original_text": "研发日报丨基石Avapritinib临床失败 罗氏Risdiplam再达3期终点",
            "features": {
                "keywords": [
                    "Avapritinib",
                    "临床失败",
                    "Risdiplam",
                    "3期终点"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "研发日报丨基石Avapritinib临床失败 罗氏Risdiplam再达3期终点",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-04-30",
            "original_text": "恒瑞医药员工卷入行贿案：年销售费用近百亿，受贿医生被判7年 其他违规处罚",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "行贿案",
                    "销售费用",
                    "违规处罚"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "恒瑞医药员工卷入行贿案：年销售费用近百亿，受贿医生被判7年 其他违规处罚",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-04-30",
            "original_text": "13亿品种，投入研发2844万，恒瑞拿下非布司他片一致性评价",
            "features": {
                "keywords": [
                    "恒瑞",
                    "非布司他片",
                    "一致性评价",
                    "研发投入"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "13亿品种，投入研发2844万，恒瑞拿下非布司他片一致性评价",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-04-30",
            "original_text": "成立以来累计亏损超5000万 南华基金何时脱困？",
            "features": {
                "keywords": [
                    "南华基金",
                    "累计亏损",
                    "脱困"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "基金"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "成立以来累计亏损超5000万 南华基金何时脱困？",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-04-30",
            "original_text": "未来十年是医药股黄金十年，创新药公司将呈现三大主线",
            "features": {
                "keywords": [
                    "医药股",
                    "黄金十年",
                    "创新药公司",
                    "三大主线"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "未来十年是医药股黄金十年，创新药公司将呈现三大主线",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-04-30",
            "original_text": "A股一季报显韧性：7成公司盈利 机构扎推医药等龙头",
            "features": {
                "keywords": [
                    "A股",
                    "一季报",
                    "盈利",
                    "医药龙头"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股一季报显韧性：7成公司盈利 机构扎推医药等龙头",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-04-30",
            "original_text": "QFII一季度青睐白马股，重仓银行医药电子",
            "features": {
                "keywords": [
                    "QFII",
                    "白马股",
                    "银行",
                    "医药",
                    "电子"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "银行",
                    "医药",
                    "电子"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "QFII一季度青睐白马股，重仓银行医药电子",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-04-30",
            "original_text": "郑眼看盘：假期风险有限 可以持股过节",
            "features": {
                "keywords": [
                    "假期风险",
                    "持股过节"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "郑眼看盘：假期风险有限 可以持股过节",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]